Indopedia All Things Marijuana
Lead photo via Flickr user Gage Skidmore
National cannabis advocacy group Americans for Safe Access (ASA) has filed two Freedom of Information Act requests in an effort to find out exactly how much information and discussion Donald Trump’s Commission on Combating Drug Addiction and the Opioid Crisis had about medical cannabis before they dismissed the all-natural medicine as an ineffective treatment and substitute for opioids.
At the beginning of November, the President’s Opioid Commission — chaired by New Jesery Gov. Chris Christie — released their final recommendations to Trump on how to best combat the deadly addiction crisis. In their report, the group suggests funneling more federal funds to addiction treatment, disseminating anti-overdose drugs to first responders across the country, and creating tougher prison sentences for people caught with the synthetic opioid fentanyl.
In line with Christie’s own political track record, the Opioid Commission chose to disregard heaps of data indicating that medical marijuana has been strong tool in the fight against opioid addiction, and instead chose to cite only one cannabis-related study, “Cannabis Use and…
